Hyperscale Data Issues Business Update to Stockholders
09 déc. 2024 06h30 HE
|
Hyperscale Data, Inc.
Hyperscale Data Issues Business Update to Stockholders
Company in Negotiations to Develop and Lease its Michigan Data Center in a Significant Transaction
BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update
12 nov. 2024 16h05 HE
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., Nov. 12, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a regenerative medicine innovator focused on stem...
Evaxion announces business update and third quarter 2024 financial results
31 oct. 2024 08h00 HE
|
Evaxion Biotech
COPENHAGEN, Denmark, October 31, 2024 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, provides business...
DHT Holdings, Inc.: Business Update
09 oct. 2024 16h15 HE
|
DHT Holdings, Inc.
HAMILTON, BERMUDA, October 9, 2024 – DHT Holdings, Inc. (NYSE:DHT) (“DHT” or the “Company”) today provides the following business update: For the third quarter of 2024, the Company estimates time...
EUROCOMMERCIAL PROPERTIES N.V.: BUYBACK PROGRAMME COMPLETED, EPRA GOLD AWARDS AND LATEST STORE OPENINGS IN CAROSELLO
30 sept. 2024 12h57 HE
|
Eurocommercial Properties N.V.
Date: 30 September 2024 Release: After closing of Euronext Please open the following link to read the full report including annexes:
Attachment
...
Altamira Therapeutics Provides Business Update and First Half 2024 Financial Results
24 sept. 2024 08h01 HE
|
Altamira Therapeutics Ltd
Hamilton, Bermuda, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Company to host conference call today at 8.30 a.m. ETContinued progress within core activities in RNA delivery, supported by move into new...
Altamira Therapeutics to Host First Half 2024 Financial Results and Business Update Call on September 24, 2024
20 sept. 2024 09h01 HE
|
Altamira Therapeutics Ltd
Hamilton, Bermuda, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Altamira Therapeutics Ltd. ("Altamira" or the "Company") (Nasdaq: CYTO), a company providing nanoparticle-based technology for efficient RNA...
Odysight.ai Reports Financial Results for the First Half of 2024 and Provides Business Update
15 août 2024 08h30 HE
|
Odysight.ai Inc.
OMER, Israel, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Odysight.ai Inc. (OTCQB: ODYS), a leading provider of visual based predictive maintenance (PdM) and condition-based monitoring (CBM) solutions,...
BioCorRx Reports Business Update for the Second Quarter of 2024
15 août 2024 08h30 HE
|
BioCorRx Inc
ANAHEIM, CA, Aug. 15, 2024 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and related disorders, today...
Biofrontera Inc. Reports Second Quarter 2024 Financial Results and Provides a Business Update
14 août 2024 16h30 HE
|
Biofrontera Inc.
Woburn, MA, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the commercialization of dermatologic products, today...